Filter
214
Filtered Results: 214
Text search:
myocarditis
Featured
Recommendations
30
New Publications
29
Language
Document type
Guidelines
85
No document type
74
Studies & Reports
29
Manuals
12
Fact sheets
11
Training Material
2
Resource Platforms
1
Countries / Regions
India
15
Argentina
10
Latin America and the Carribbean
9
Brazil
8
Venezuela
6
Paraguay
6
Indonesia
6
Colombia
5
Global
5
Africa
5
Germany
5
South Africa
5
Rwanda
4
Bolivia
3
Ecuador
3
El Salvador
2
Philippines
2
Mozambique
2
USA
2
Tanzania
2
West and Central Africa
2
Western and Central Europe
2
Bangladesh
2
Nepal
1
Kenya
1
Ukraine
1
Lesotho
1
Ghana
1
Sierra Leone
1
Chile
1
Nigeria
1
Peru
1
Malawi
1
Zimbabwe
1
Congo, Democratic Republic of
1
Western Pacific Region
1
East and Southern Africa
1
Uganda
1
Nicaragua
1
Russia
1
Ethiopia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
97
Clinical Guidelines
36
Public Health
10
Women & Child Health
10
Capacity Building
1
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
70
NTDs
19
Rapid Response
14
NCDs
10
Mental Health
7
HIV
5
Caregiver
4
Refugee
3
Ebola
3
Pharmacy
3
Zika
2
AMR
2
Natural Hazards
1
TB
1
Planetary Health
1
Conflict
1
La miocarditis es una enfermedad inflamatoria con compromiso focal o difuso del miocardio, que se presenta de forma fulminante, pudiendo ser aguda, subaguda o crónica.Las que poseen un nivel de gravedad suficiente para reconocerlas clínicamente, son raras, pero la prevalencia de los casos leves y ...
Existen notificaciones de eventos relacionados con la vacuna (ESAVI) de
miocarditis/pericarditis en adolescentes tras la administración de vacunas ARNm(Pfizer y Moderna) especialmente tras la segunda dosis. Al momento no seencuentra asociación entre la enfermedad y la administración de la vacuna...
Background: East African trypanosomiasis is an uncommon, potentially lethal disease if not diagnosed and treated in a timely manner. South Africa, as a centre for emergency medical evacuations from much of sub-Saharan Africa, receives a high proportion of these patients, mostly tourists and expatria...
Diphtheria is caused by Corynebacterium species, mostly by toxin-producing Corynebacterium diphtheriae and rarely by toxin-producing strains of C. ulcerans and C. pseudotuberculosis. The most common type of diphtheria is classic respiratory diphtheria, whereby the exotoxin produced characteristicall...
Dispõe sobre orientações para identificação, investigação e manejo do evento adverso pós vacinação de miocardite/pericardite no contexto da vacinação contra a COVID-19 no Brasil
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
short information on flu and the annual vaccination for people of age 60+ in germany
also available in german, turkish, russian, arabic on
https://www.bzga.de/infomaterialien/impfungen-und-persoenlicher-infektionsschutz/grippeimpfung/grippeimpfung-der-richtige-schritt-fuer-einen-sicheren-schutz/...
Campaña Nacional de Vacunación contra la COVID-19
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3026 (Published 11 August 2020)
The BMJ "practice pointer" inlcudes a one-page visual summary of assessment and initial management of patients with persistant symptoms following acute SARS-CoV-2 infection
